Atopica 50 mg (Cyclosporine CAPSULE) 50 MG

Atopica 50 mg capsules contain cyclosporine, an immunosuppressant used to manage immune-mediated conditions. This oral medication is commonly prescribed for dogs to help control allergic reactions and inflammatory responses.

Strength

50 MG

Pack Size

15/30

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Atopica 50 mg capsules are primarily used to manage immune-mediated conditions in dogs. Cyclosporine works by suppressing the immune system, which can help alleviate symptoms associated with allergies and inflammatory disorders. This medication is often recommended for conditions such as atopic dermatitis, where the immune system overreacts to environmental allergens.

Side Effects

Common effects of Atopica 50 mg capsules may include gastrointestinal upset, such as vomiting or diarrhea. Some pets may also experience lethargy or changes in appetite. These effects are generally mild and temporary, but persistent or severe reactions should be discussed with a veterinarian.

Precautions & Warnings

Atopica 50 mg capsules should be handled with care, as cyclosporine can be irritating to the skin and eyes. It is important to follow the prescribed dosage and administration instructions provided by a veterinarian. Regular monitoring may be required to ensure the medication is working effectively and to check for any potential side effects.

Avoid Interactions

Cyclosporine can interact with various medications, including certain antibiotics, antifungals, and other immunosuppressants. It is important to inform your veterinarian about all medications your pet is currently taking to avoid potential interactions. Additionally, grapefruit and grapefruit juice should be avoided, as they can affect the metabolism of cyclosporine.

Frequently Asked Questions

Atopica 50 mg capsules are used to manage immune-mediated conditions in dogs, such as atopic dermatitis and other allergic reactions.

Atopica 50 mg capsules should be administered orally, typically with food, as directed by a veterinarian.

Common side effects may include gastrointestinal upset, lethargy, and changes in appetite. Severe or persistent effects should be discussed with a veterinarian.

Cyclosporine can interact with various medications, so it is important to consult a veterinarian before combining it with other treatments.

Long-term use of Atopica 50 mg should be monitored by a veterinarian to ensure its continued safety and effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.